Cutting HIV and Aids treatments costs in South Africa


India is among the fastest growing pharmaceutical markets in the world, establishing itself as a global manufacturing and research hub.

About 15% of their pharmaceutical exports arrive in Africa and in South Africa the availability of generic anti-retrovirals (ARVs) from India has led to a significant drop in the cost of treatment for millions of people with Human Immunodeficiency Virus (HIV) or Acquired Immune Deficiency Syndrome (Aids).

The BBC’s Taurai Maduna has more for Africa Business Report.



Source link